Case 1 - BASILICA with Unicorn

Adam Greenbaum, MD, joined Emory after serving at Henry Ford Heart and Vascular Institute in Detroit, Michigan for the past 19 years as Co-director of the Center for Structural Heart Disease, Director of the Cardiac Catheterization Laboratory and Director of the Interventional Fellowship Program. He has dedicated his career to patient care, clinical research and fellow and resident education. Dr. Greenbaum has received numerous patient care and teaching awards, and is recognized as a clinical expert in the field of structural heart disease. His breakthrough research surrounding structural heart problems and the minimally invasive techniques he developed as a result, gives patients new treatment options. And his novel transcatheter methods and approaches to valvular heart disease bring new hope to patients with no other options. He is board certified in general and interventional cardiology and is a Fellow of the American College of Cardiology, the American Heart Association and the Society for Cardiovascular Angiography and Interventions. Dr. Greenbaum graduated from the New York University School of Medicine in New York, NY. He completed his internal medicine training at the University of Michigan in Ann Arbor, MI and his general and interventional cardiology training at Duke University in Durham, NC.

David Hildick-Smith is an interventional Cardiologist of national and international renown. He undertakes procedures such as angioplasty, patent foramen ovale closure, atrial septal defect closure, left atrial appendage occlusion, transcatheter valve implantation and transcatheter mitral valve interventions. He does echocardiography onsite for relevant patients. He undertakes over 300 interventions per year at the Sussex Cardiac Centre and is Structural Heart lead for the British Cardiovascular Interventions Society.

Dr. Gaetano Paone is a member of the Emory Structural Heart and Valve Center, where he focuses on valve repair and replacement, coronary artery bypass graft surgery (CABG), transcatheter aortic valve replacement (TAVR), and other related, less invasive valve technologies. Dr. Paone earned his MD at New York University School of Medicine, and completed his general surgery residency at New York University Medical Center. After completing his thoracic surgery residency at the University of Illinois Hospitals, he joined the cardiothoracic surgery faculty at Boston University Medical Center. In 1990, Dr. Paone joined Henry Ford Hospital in Detroit. Dr. Paone also practiced at Crittenton Hospital Medical Center in Rochester, MI, from 2004-2009, and obtained his Masters in Health Service Administration from the University of Michigan School of Public Health in 2006. In 2009, he returned to Henry Ford Hospital, where he served as chief of the Division of Cardiac Surgery for nine years.

Jaffar is Director of Cardiovascular Innovation and Director of Interventional Electrosurgery at St Francis Hospital and Heart Center, Roslyn, NY. He performs research at the Laboratory of Cardiac Intervention, NHLBI, NIH. He led the invention of transcatheter electrosurgical techniques to cut heart tissue, and together with a team of dedicated physicians and creative thinkers, invented several novel transcatheter procedures and devices that have been translated into clinical practice. He received his undergraduate degree at Cambridge as a Scholar, medical degree at Oxford with merits, and an award-winning PhD in cardiovascular sciences at King’s College London. He completed training in Oxford, London, and Washington DC. He has written over 130 peer-reviewed manuscripts and has given over 50 invited lectures, including 4 late breaking clinical trial presentations. He is a regular live case operator.

Dr. James Harvey, MD, FACC is an Interventional Cardiologist with WellSpan Health. He attended undergraduate and graduate school at Vanderbilt University and then went to medical school at the University of South Florida College of Medicine. Dr. Harvey then did his residency training in Internal Medicine at Emory University Hospital in Atlanta, GA and completed fellowship training in both Cardiovascular Medicine and Interventional Cardiology at the Cleveland Clinic in Cleveland, OH where he served as the chief interventional fellow. Board-certified in Cardiovascular Medicine and Interventional Cardiology, Dr. Harvey has a special interest in structural and valvular heart disease, complex coronary artery disease, and mechanical cardiovascular circulatory support. He is the Director of the Cardiac Catheterization Laboratory and the Structural Heart Program at WellSpan York Hospital. He also serves as a member of the Executive Council for the Pennsylvania Chapter of the American College of Cardiology.

Dr. Patrick T. Gleason is an Assistant Professor at Emory University / Emory Healthcare, specializing in general non-invasive cardiology. He is part of the Emory Structural Heart and Valve team.

Dr. Paul Mahoney is the Director of the Structural Heart and Complex High Risk Intervention Programs at Sentara Health, a 14 Hospital System in Virginia and North Carolina. He has extensive clinical experience in transcatheter aortic and mitral valve replacement, mitral edge to edge repair, and left atrial appendage closure. He leads the complex high risk PCI team at Sentara Health. Dr. Mahoney has served as local PI in many clinical research trials including PARTNER, SURTAVI, TRILLUMINATE, TRISCEND, REPAIR MR, SMART TRIAL, OPTIMIZE PRO, EXCEL, PORTICO, APOLLO, EARLY TAVR, EXCEED, EXPAND, SYNTAX, M3 and dozens of others.

Philip Freeman is an Interventional Cardiologist & Senior Lecturer at the Aalborg University Hospital, Denmark

Dr Lederman is the chief of the Laboratory of Cardiovascular Intervention at the NHLBI Division of Intramural Research in Bethesda Maryland USA. His program creates new catheter treatments & devices for structural heart disease and introduces them into medical practice. His multidisciplinary team includes cardiologists, imaging physicists, and biomedical engineers. The NHLBI Lederman lab has created and translated into clinical practice several novel procedures including transcaval access to the aorta; mitral cerclage ventriculoplasty; LAMPOON, ELASTIC, and BASILICA leaflet modification to allow TMVR and TAVR; myocardial intramural navigation procedures including MIRTH ventriculoplasty, SESAME myotomy, and VINTAGE ablation; and MRI heart catheterization. These procedures and protocols are possible though a network of luminary collaborating structural heart interventional cardiologists.

Dr. Rogers is an interventional cardiologist and scientific lead for the MedStar Heart & Vascular Institute Structural Heart Disease program. He has a special interest in all aspects of minimally invasive treatment of structural heart disease, including Transcatheter Aortic Valve Replacement (TAVR), Transcaval access, Transcatheter Electrosurgery (LAMPOON and BASILICA techniques), para-valvular leak closure, percutaneous treatment of mitral valve regurgitation including Mitraclip and Transcatheter Mitral Valve Replacement (TMVR), LAA occluder, percutaneous pulmonary and tricuspid valve interventions, and cerebral protection devices for TAVR.

Zuyue Wang works at MedStar Washington Hospital Center, Washington, District of Columbia, USA.